| |
|
|
|
Celldex Therapeutics
|
|
2.33 -0.03 (-1.27%) |
8/18/2017 4:00pm |
|
Open: |
2.34 |
Pre close: |
2.36 |
Target:
|
3.02
|
|
High: |
2.35 |
Low: |
2.30 |
Resistance:
|
2.59
2.78
|
|
Volume: |
726,077 |
Market Cap: |
299.04M |
Support:
|
2.27
1.89
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.40
 |
MACD |
MACD(12,26):
|
-0.02 |
|
MA(20): |
2.43 |
Signal(12,26,9): |
-0.02 |
|
MA(100): |
2.80 |
Stochastic Oscillator |
%K(14,3):
|
18.37 |
|
MA(250): |
3.30 |
%D(3): |
26.38 |
|
Average Volume(K) |
3-Month: |
169437
|
52-Week |
High:
|
5.02 |
|
10-Days: |
57827 |
Low: |
2.20 |
|
RSI |
RSI(14):
|
40.83 |
Change(%): |
-40.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.190 |
Return on Equity (ttm) |
-50.5 |
Shares Out. (M) |
125.11 |
|
EPS Est. Current Year |
-1.050 |
Return on Assets (ttm) |
-23.5 |
Shares Float (M) |
117.57 |
|
EPS Est. Next Year |
-1.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.54 |
|
EPS Est. Next Quarter |
-0.280 |
Qtrly Rev. Growth |
17.7 |
% Held by Institutions |
89.20 |
|
Forward EPS |
-1.031 |
Gross Profit (p.s.) |
0.054 |
Shares Short (K) |
17880 |
|
Book Value (p.s.) |
2.000 |
EBITDA (p.s.) |
-0.957 |
P/E |
-1.96 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.16 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-113.40 |
P/S |
4858438144.00 |
|
Operating Margin |
-1773.41 |
Levered Free Cash Flow
(M) |
-58.54 |
P/CF |
-2.57 |
|
|
|
|
 |
|
|
|
